Hepatotoxicity associated with use of D-penicillamine in rheumatoid arthritis

J. Rosenbaum; W. A. Katz; H. R. Schumacher

doi:10.1136/ard.39.2.152

Hepatotoxicity associated with use of D-penicillamine in rheumatoid arthritis

J. Rosenbaum, W. A. Katz, H. R. Schumacher

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Abstract

Two patients with rheumatoid arthritis developed evidence of hepatotoxicity while receiving D-penicillamine. Both recovered after withdrawal of the drug. These cases and a review of the literature suggested that hepatotoxicity, though rare, should be added to the list of adverse reactions to D-penicillamine.

Original language	English (US)
Pages (from-to)	152-154
Number of pages	3
Journal	Annals of the rheumatic diseases
Volume	39
Issue number	2
DOIs	https://doi.org/10.1136/ard.39.2.152
State	Published - 1980
Externally published	Yes

ASJC Scopus subject areas

Rheumatology
Immunology and Allergy
Immunology
General Biochemistry, Genetics and Molecular Biology

Access to Document

10.1136/ard.39.2.152

Cite this

@article{30e6a2727b0946f2afc28779a896a7fb,

title = "Hepatotoxicity associated with use of D-penicillamine in rheumatoid arthritis",

abstract = "Two patients with rheumatoid arthritis developed evidence of hepatotoxicity while receiving D-penicillamine. Both recovered after withdrawal of the drug. These cases and a review of the literature suggested that hepatotoxicity, though rare, should be added to the list of adverse reactions to D-penicillamine.",

author = "J. Rosenbaum and Katz, {W. A.} and Schumacher, {H. R.}",

year = "1980",

doi = "10.1136/ard.39.2.152",

language = "English (US)",

volume = "39",

pages = "152--154",

journal = "Annals of the rheumatic diseases",

issn = "0003-4967",

publisher = "BMJ Publishing Group",

number = "2",

}

TY - JOUR

T1 - Hepatotoxicity associated with use of D-penicillamine in rheumatoid arthritis

AU - Rosenbaum, J.

AU - Katz, W. A.

AU - Schumacher, H. R.

PY - 1980

Y1 - 1980

N2 - Two patients with rheumatoid arthritis developed evidence of hepatotoxicity while receiving D-penicillamine. Both recovered after withdrawal of the drug. These cases and a review of the literature suggested that hepatotoxicity, though rare, should be added to the list of adverse reactions to D-penicillamine.

AB - Two patients with rheumatoid arthritis developed evidence of hepatotoxicity while receiving D-penicillamine. Both recovered after withdrawal of the drug. These cases and a review of the literature suggested that hepatotoxicity, though rare, should be added to the list of adverse reactions to D-penicillamine.

UR - http://www.scopus.com/inward/record.url?scp=0018827509&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018827509&partnerID=8YFLogxK

U2 - 10.1136/ard.39.2.152

DO - 10.1136/ard.39.2.152

M3 - Article

C2 - 7387219

AN - SCOPUS:0018827509

SN - 0003-4967

VL - 39

SP - 152

EP - 154

JO - Annals of the rheumatic diseases

JF - Annals of the rheumatic diseases

IS - 2

ER -

Hepatotoxicity associated with use of D-penicillamine in rheumatoid arthritis

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this